[ Price : $8.95]
The ACLU files a lawsuit seeking to force FDA to release documents related to its ongoing safety review of mifepristone.[ Price : $8.95]
FDA says it is approving new labeling submitted by Sarepta Therapeutics for its gene therapy Elevidys (delandistrogene moxeparvove...[ Price : $8.95]
FDA grants Parabilis Medicines a fast track designation for FOG-001, a first-in-class inhibitor targeting the β-catenin:TCF i...[ Price : $8.95]
Medical ethicist Arthur Caplan voices concerns about human subject protection in clinical trials due to significant staff cuts at ...[ Price : $8.95]
A Wiley Rein petition filed for a client asks FDA to order the immediate withdrawal of Wells Pharmas compounded 100 mg indomethaci...[ Price : $8.95]
FDA approves Shanghai Henlius Biologics Poherdy (pertuzumab-dpzb), the first interchangeable biosimilar to Genentechs Perjeta (per...[ Price : $8.95]
University of Chicago researchers explain how difficult it will be to improve government oversight over social media influencer pr...[ Price : $8.95]
FDA qualifies glutamate hydrogenase as a biomarker to enhance liver safety monitoring in clinical trials.